13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001687509
Total reported value
$10.9B
$10.9B
67 檔
10.3%
During the Q2 2024 filing period, Rubric Capital Management LP (CIK: 0001687509) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $10.9B across 67 reported positions.
In Q2 2024, Rubric Capital Management LP displayed an active expansion posture, initiating 5 new positions and adding to 25 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 7.35% | -0.03% | -2.31% | |
| 2 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 6.37% | +0.48% | +15.00% | |
| 3 | GLNG | Golar LNG Limited | Stock-Energy | 5.95% | -1.06% | +11.19% | |
| 4 | VTRS | Viatris Inc | Stock-Healthcare | 5.61% | +0.19% | +9.23% | |
| 5 | BGC | Bgc Group Inc-a | Stock-Financials | 4.13% | -0.08% | — | |
| 6 | FLR | Fluor CORP | Stock-Industrials | 3.67% | +2.41% | NEW | |
| 7 | 07WA | Mr Cooper Group Inc | Stock-Other | 3.23% | — | — | |
| 8 | QDEL | Quidelortho CORP | Stock-Other | 3.18% | -0.05% | +51.90% | |
| 9 | VST | Vistra CORP | Stock-Utilities | 2.99% | +0.22% | +9.32% | |
| 10 | LBTYA | Liberty Global Ltd. | Stock-Other | 2.53% | -0.28% | +43.71% | |
| 11 | HRTX | Heron Therapeutics Inc | Stock-Other | 2.45% | -0.13% | — | |
| 12 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 2.39% | -0.07% | +30.71% | |
| 13 | RNW | ReNew Energy Global Plc | Stock-Other | 2.21% | +0.10% | +15.32% | |
| 14 | COLL | Collegium Pharmaceutical Inc | Stock-Other | 1.97% | -0.03% | +27.23% | |
| 15 | CAR | Avis Budget Group Inc | Stock-Other | 1.89% | — | +220.92% | |
| 16 | EXTR | Extreme Networks Inc | Stock-Other | 1.85% | — | +52.31% | |
| 17 | CSTM | Constellium SE | Stock-Other | 1.81% | — | +0.90% | |
| 18 | AMRX | Amneal Pharmaceuticals Inc | Stock-Other | 1.79% | +0.16% | +12.36% | |
| 19 | MATV | Mativ Holdings Inc | Stock-Other | 1.78% | -0.09% | — | |
| 20 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 1.73% | — | — | |
| 21 | PTVEUSD | Pactiv Evergreen Inc | Stock-Other | 1.70% | — | +3.34% | |
| 22 | DOLE | Dole plc | Stock-Other | 1.65% | — | — | |
| 23 | LBTYA | Liberty Global Ltd. | Stock-Other | 1.64% | -0.22% | +85.44% | |
| 24 | ALIT | Alight Inc - Class A | Stock-Other | 1.63% | — | — | |
| 25 | MD | Pediatrix Medical Group Inc | Stock-Other | 1.61% | — | +796.98% | |
| 26 | SDGR | Schrodinger Inc | Stock-Other | 1.59% | +0.23% | +213.54% | |
| 27 | OPK | Opko Health Inc | Stock-Other | 1.46% | +0.08% | +800.00% | |
| 28 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 1.44% | -0.01% | +12.94% | |
| 29 | ADEA | Adeia Inc | Stock-Other | 1.36% | -0.45% | — | |
| 30 | ADPT | Adaptive Biotechnologies | Stock-Other | 1.33% | — | +33.33% | |
| 31 | SSYS | Stratasys Ltd. | Stock-Other | 1.31% | -0.03% | +18.19% | |
| 32 | OFIX | Orthofix Medical Inc | Stock-Other | 1.28% | -0.14% | +0.82% | |
| 33 | PLAY | Dave & Buster's Entertainmen | Stock-Other | 1.28% | — | +104.68% | |
| 34 | TDOC | Teladoc Health Inc | Stock-Healthcare | 1.19% | — | — | |
| 35 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 1.18% | +0.44% | — | |
| 36 | VYX | Ncr Voyix CORP | Stock-Tech | 1.11% | — | -24.40% | |
| 37 | AIR | Aar CORP | Stock-Industrials | 1.10% | — | -20.69% | |
| 38 | ANIP | Ani Pharmaceuticals Inc | Stock-Other | 1.01% | +0.20% | NEW | |
| 39 | XPER | Xperi Inc | Stock-Other | 0.89% | +0.06% | +2.47% | |
| 40 | ZYME | Zymeworks Inc | Stock-Other | 0.87% | -0.18% | +12.72% | |
| 41 | TAC | Transalta CORP | Stock-Other | 0.87% | +0.10% | — | |
| 42 | GDRX | Goodrx Holdings Inc-class A | Stock-Other | 0.76% | — | +76.51% | |
| 43 | FIP | Ftai Infrastructure Inc | Stock-Other | 0.72% | — | — | |
| 44 | RSKD | Riskified Ltd. | Stock-Other | 0.70% | — | — | |
| 45 | CNNE | Cannae Holdings Inc | Stock-Other | 0.68% | — | +17.79% | |
| 46 | CHRS | Coherus Oncology Inc | Stock-Other | 0.47% | — | — | |
| 47 | SCPH | Scpharmaceuticals Inc | Stock-Other | 0.40% | — | — | |
| 48 | CRS | Carpenter Technology | Stock-Industrials | 0.40% | — | +77.73% | |
| 49 | TRVI | Trevi Therapeutics Inc | Stock-Other | 0.39% | -0.04% | -9.65% | |
| 50 | SSTK | Shutterstock Inc | Stock-Other | 0.39% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | JAZZ | Jazz Pharmaceuticals plc | +1.7% | NEW | New buy |
| 2 | ALIT | Alight Inc - Class A | +1.6% | NEW | New buy |
| 3 | MD | Pediatrix Medical Group Inc | +1.3% | +796.98% | Add |
| 4 | GLNG | Golar LNG Limited | +1.3% | +11.19% | Add |
| 5 | OPK | Opko Health Inc | +1.3% | +800.00% | Add |
| 6 | TDOC | Teladoc Health Inc | +1.2% | NEW | New buy |
| 7 | KNSA | Kiniksa Pharmaceuticals International, plc | +1.2% | NEW | New buy |
| 8 | CAR | Avis Budget Group Inc | +1.1% | +220.92% | Add |
| 9 | SDGR | Schrodinger Inc | +0.8% | +213.54% | Add |
| 10 | EXTR | Extreme Networks Inc | +0.7% | +52.31% | Add |
| 11 | LBTYA | Liberty Global Ltd. | +0.7% | +85.44% | Add |
| 12 | LBTYA | Liberty Global Ltd. | +0.6% | +43.71% | Add |
| 13 | VST | Vistra CORP | +0.5% | +9.32% | Add |
| 14 | FLR | Fluor CORP | +0.4% | +23.64% | Add |
| 15 | SSTK | Shutterstock Inc | +0.4% | NEW | New buy |
| 16 | ADPT | Adaptive Biotechnologies | +0.3% | +33.33% | Add |
| 17 | GDRX | Goodrx Holdings Inc-class A | +0.3% | +76.51% | Add |
| 18 | HRTX | Heron Therapeutics Inc | +0.3% | — | Unchanged |
| 19 | CRS | Carpenter Technology | +0.2% | +77.73% | Add |
| 20 | ARQT | Arcutis Biotherapeutics Inc | +0.2% | +30.71% | Add |
| 21 | PLAY | Dave & Buster's Entertainmen | +0.2% | +104.68% | Add |
| 22 | ROIV | Roivant Sciences Ltd. | +0.1% | +15.00% | Add |
| 23 | RNW | ReNew Energy Global Plc | +0.1% | +15.32% | Add |
| 24 | FIP | Ftai Infrastructure Inc | +0.1% | — | Unchanged |
| 25 | MREO | Mereo Biopharma Group Pl-adr | +0.1% | +12.94% | Add |
| 26 | AMRX | Amneal Pharmaceuticals Inc | +0.1% | +12.36% | Add |
| 27 | TEVA | Teva Pharmaceutical-sp Adr | 0% | -2.31% | Trim |
| 28 | RVNCEUR | Revance Therapeutics Inc | -0.2% | — | Unchanged |
| 29 | HOWL | Werewolf Therapeutics Inc | -0.2% | -17.71% | Trim |
| 30 | QDEL | Quidelortho CORP | -0.2% | +51.90% | Add |
| 31 | BGC | Bgc Group Inc-a | -0.2% | — | Unchanged |
| 32 | CHRS | Coherus Oncology Inc | -0.3% | — | Unchanged |
| 33 | CGEM | Cullinan Therapeutics Inc | -0.3% | EXIT | Sold out |
| 34 | OVID | Ovid Therapeutics Inc | -0.4% | — | Unchanged |
| 35 | SSYS | Stratasys Ltd. | -0.4% | +18.19% | Add |
| 36 | MATV | Mativ Holdings Inc | -0.4% | — | Unchanged |
| 37 | XPER | Xperi Inc | -0.6% | +2.47% | Add |
| 38 | CSTM | Constellium SE | -0.6% | +0.90% | Add |
| 39 | NUVL | Nuvalent Inc-a | -0.6% | EXIT | Sold out |
| 40 | KOP | Koppers Holdings Inc | -0.6% | -36.88% | Trim |
| 41 | VYX | Ncr Voyix CORP | -0.6% | -24.40% | Trim |
| 42 | SWTXUSD | Springworks Therapeutics Inc | -0.6% | EXIT | Sold out |
| 43 | PTVEUSD | Pactiv Evergreen Inc | -0.7% | +3.34% | Add |
| 44 | PARR | Par Pacific Holdings Inc | -0.9% | EXIT | Sold out |
| 45 | VTRS | Viatris Inc | -0.9% | +9.23% | Add |
| 46 | ANIP | Ani Pharmaceuticals Inc | -1% | -37.01% | Trim |
| 47 | ✓ | Playa Hotels & Resorts NV | -1% | -75.03% | Trim |
| 48 | ATMU | Atmus Filtration Technologie | -1.1% | EXIT | Sold out |
| 49 | KNSA | Kiniksa Pharmaceuticals International, plc | -1.3% | EXIT | Sold out |
| 50 | IBIT | Ishares Bitcoin Trust ETF | -2.1% | EXIT | Sold out |
According to official SEC Form 13F filings, Rubric Capital Management LP reported a total U.S. public equity portfolio value of $10.9B across 67 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TEVA, ROIV, GLNG) accounted for 10.3% of total reported equity market value during Q2 2024.
Top New Position Initiated
JAZZ
市值: $65.8M
Top Position Liquidated / Trimmed
IBIT
前期市值: $69.7M
During Q2 2024, Rubric Capital Management LP's top holdings by market value included TEVA (7.3%)、ROIV (6.4%)、GLNG (6.0%). The largest single position, TEVA, represented 7.3% of total portfolio value.
In Q2 2024, Rubric Capital Management LP made 43 total portfolio adjustments, initiating 5 new buys, adding to 25 positions, trimming 6 holdings, and fully liquidating 7 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.